Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
GlobeNewswire (May 9, 2013)
-
GlobeNewswire (May 7, 2013)
-
GlobeNewswire (Apr 15, 2013)
-
GlobeNewswire (Apr 9, 2013)
-
GlobeNewswire (Apr 9, 2013)
-
GlobeNewswire (Mar 20, 2013)
-
GlobeNewswire (Mar 19, 2013)
-
GlobeNewswire (Feb 6, 2013)
To learn more about Seeking Alpha Pro, click here.
-
StemCells Q3 2011 EarningsHenry McCusker • Mon, Nov 7, 2011
-
Global Factors Boosting Biotech TodayResearch Recap • Tue, Aug 24, 2010
-
StemCells' CEO Discusses Q3 2012 Results - Earnings Call TranscriptFri, Nov 9, 2012 • 1 Comment
-
StemCells' CEO Discusses Q2 2012 Results - Earnings Call TranscriptMon, Aug 6, 2012
-
GlobeNewswire (May 9, 2013)
-
GlobeNewswire (May 7, 2013)
-
GlobeNewswire (Apr 15, 2013)
-
GlobeNewswire (Apr 9, 2013)
-
GlobeNewswire (Apr 9, 2013)
-
GlobeNewswire (Mar 20, 2013)
-
GlobeNewswire (Mar 19, 2013)
-
at MarketWatch.com (Feb 12, 2013)
-
GlobeNewswire (Feb 6, 2013)
-
GlobeNewswire (Jan 23, 2013)
-
GlobeNewswire (Nov 29, 2012)
-
GlobeNewswire (Nov 8, 2012)
-
GlobeNewswire (Nov 5, 2012)
-
GlobeNewswire (Oct 30, 2012)
-
GlobeNewswire (Oct 26, 2012)
-
GlobeNewswire (Oct 17, 2012)
STEM vs. ETF Alternatives
Company Description
StemCells, Inc. is engaged in the research, development, and commercialization of stem cell therapeutics and related enabling technologies for academia and industry. We believe that understanding cells and cell biology, and in particular stem cells, will play an increasingly important role in... More











